Biocon

L24234KA1978PLC003417 · ISIN INE376G01013 · 4 filings, FY 2022-23 to FY 2025-26 · consolidated basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

category_row_disappeared. FY 2025-26 omits other, filed in this company's other years. Absence is not a reported zero.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Consolidated basis, FY 2023-24 Consolidated basis, FY 2024-25 Consolidated, FY 2025-26 Consolidated. Year-on-year figures cover different entities.

CategoryFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Plastics including packaging not filednot filed420
E-waste not filednot filed200
Hazardous waste not filednot filed33,5200
Other waste 13,728.2not filed23,518not filed
Total reclaimed 13,728.2057,1000

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Process Solvents 54.0%47.0%42.1%not filed

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
021 Manufacture of pharmaceuticals, medicinal chemical, and botanical products 100.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Consolidated basis 2023-06-30 75,76,70,00,000
FY 2023-24 Consolidated basis 2024-04-30 23,30,20,00,000
FY 2024-25 Consolidated 2025-05-31 24,84,90,00,000
FY 2025-26 Consolidated 2026-02-28 23,46,39,07,803

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error